Windlas Biotech consolidated net profit rises 11.62% in the September 2024 quarter

Net profit of Windlas Biotech rose 11.62% to Rs 15.66 crore in the quarter ended September 2024 as against Rs 14.03 crore during the previous quarter ended September 2023. Sales rose 22.49% to Rs 187.00 crore in the quarter ended September 2024 as against Rs 152.67 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	187.00	152.67	22
OPM %	12.33	12.24	-
PBDT	26.79	21.64	24
PBT	20.29	18.31	11
NP	15.66	14.03	12